Halo logo
Marketplace
For Industry Partners
For Innovators
Contact sales
Sign in
Join now
DS
Dr vaishali Shirsat
Principal Investigator
Bombay College of Pharmacy
I'm working on
7 months ago
Diroximel Fumarate for Multiple Sclerosis: Innovative Capsule
About
We (IQGEN-X company and college) aimed to formulate a single 462 mg DRF capsule, in a delayed-release format, as an alternative to the current regimen of Vumerity®, a marketed product administered as two capsules of 231 mg each capsule. In vitro dissolution studies assessed drug release patterns.
DS
Dr vaishali Shirsat
Principal Investigator
Bombay College of Pharmacy
Work experience
Bombay College of Pharmacy
Principal Investigator
Top industry applications
Pharmaceuticals and drug delivery
Open to opportunities in
Analytical ChemistryDrug DeliveryIndustrial ChemistryNanotechnologyPharmaceutical Chemistry
Last updated Mar 2026
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
Company
AboutBlogCareersHalo Awards
Support
FAQsHelp center
Contact support
Sponsors
Customer stories
Privacy PolicyTerms of Service
© 2026 Halo Cures, Inc.